BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Clinical trial NCT06773481 · RECRUITING

Trial details

NCT number: NCT06773481
Sponsor: Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Glioma Tumor Recurrence Glioma, Recurrent High Grade Glioblastomas (GBM)Glioblastoma WHO Grade IV

Start date: 2025-04-07
Primary completion: 2026-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.